- June 13, 2025
To Understand Alzheimer’s Disease, Researchers Turn to Myelin Sheath
- April 17, 2025
Reduced Deep and REM Sleep Could be Early Markers of Alzheimer’s
- April 08, 2025Source: for Humanity
Unlocking the Mysteries of Memory Loss
- March 07, 2025
Announcing the Carol and Gene 2025 Pilot Grant Program Awardees
- July 25, 2024Source: Everyday Health
Can Anxiety Raise Your Dementia Risk? New Study Finds a Link
- June 13, 2024Source: MedPage Today
APOE Genotypes and Dementia
Carol and Gene Ludwig Program for the Study of Neuroimmune Interactions in Dementia
The Carol & Gene Ludwig Program for the Study of Neuroimmune Interactions in Dementia operates as a central home at Yale for the study of neurology, neuroscience, and immunobiology interactions as they relate to the dementias and specifically Alzheimer's. Alzheimer’s is currently ranked as the seventh leading cause of death in the United States and is the most common cause of dementia among older adults.
About the Ludwig Program
The Carol & Gene Ludwig Program for the Study of Neuroimmune Interactions in Dementia will transform the field of neuroinflammation with the goal of identifying new pathways and interactions, facilitating fundamental discoveries across many platforms, and providing new nodes for therapeutic intervention.
Ludwig Pilot Grant Program
This program provides crucial seed money for investigators to explore innovative new directions and gather preliminary data for future funding opportunities.
Ludwig Program Seminar Series
The Ludwig Program Seminar Series focuses on the topics of neuroimmunity, neuroinflammation, inflammation, dementia, and Alzheimer's disease, and is led by Yale and national leaders in these topics.